Other
Net Change in Cash
Pfizer Net Change in Cash increased by 164.3% to $563.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 50.1%, from $375.00M to $563.00M. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementCash Flow Statement
SectionOther
CategoryLiquidity
SignalHigher is better
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
A positive change indicates net cash generation, while a negative change indicates cash consumption for the period.
Detailed definition
The total net increase or decrease in cash, cash equivalents, and restricted cash during the reporting period. It is the...
Peer comparison
A fundamental liquidity metric used to compare cash management efficiency across all public companies.
Metric ID:
net_change_in_cashHistorical Data
13 periods
| Q2 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $608.00M | $529.00M | -$688.00M | -$487.00M | -$869.00M | $1.75B | $475.00M | $535.00M | -$2.14B | -$45.00M | $375.00M | $213.00M | $563.00M |
| QoQ Change | — | -13.0% | -230.1% | +29.2% | -78.4% | +301.8% | -72.9% | +12.6% | -499.4% | +97.9% | +933.3% | -43.2% | +164.3% |
| YoY Change | — | — | -213.2% | — | — | +231.6% | +169.0% | +209.9% | -221.8% | — | +117.5% | — | +50.1% |
Range-$2.14B – $1.75B
CAGR-2.5%
Avg YoY Growth+49.0%
Median YoY Growth+117.5%
Net Change in Cash at Other Companies
Frequently Asked Questions
- What is Pfizer's net change in cash?
- Pfizer (PFE) reported net change in cash of $563.00M in Q1 2026.
- How has Pfizer's net change in cash changed year-over-year?
- Pfizer's net change in cash increased by 50.1% year-over-year, from $375.00M to $563.00M.
- What does net change in cash mean?
- The total change in the company's cash position over the period.